Organon & Co. SEC filings OGN
Organon & Co. has 461 filings in SEC EDGAR's recent list, going back to Nov 2, 2020. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| 10-K/A | Amended annual report | Nov 10, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 26, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 27, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 21, 2022 | Dec 31, 2021 |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OGN (NYSE)
- Fiscal year ends
- December 31
- Headquarters
- Jersey City, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1821825
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.